Effect of enteral nutrition on exocrine pancreatic function

G. Bodoky(Unified Szent István and Szent László Hospital), Ákos Pap(University of Szeged), L Flautner(Semmelweis University), László Harsányi(Semmelweis University), Tibor Tihanyi(Semmelweis University)

The American Journal of Surgery

January 1, 1991

10.1016/0002-9610(91)90375-n

Cited by 83

Related Papers

ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making

|Annals of Oncology|2012|1.5k

ESPEN Guidelines on Enteral Nutrition: Surgery including Organ Transplantation

|Clinical Nutrition|2006|1.1k

Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study

|The Lancet Oncology|2015|954

Capecitabine and cisplatin with or without cetuximab for patients with previously untreated advanced gastric cancer (EXPAND): a randomised, open-label phase 3 trial

|The Lancet Oncology|2013|838

Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer

|Annals of Oncology|2014|603